Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 617.0 -2.72%

Годовой отчет за 2024 год
добавлен 05.02.2025

report update icon

Regeneron Pharmaceuticals Мультипликаторы 2011-2025 | REGN

Мультипликаторы по годам Regeneron Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

17.6 25.3 19.3 8.3 14.8 17.4 18.5 33.7 40.3 68.1 120.4 67.6 22.1 -36.3

P/S

5.5 7.6 6.9 4.2 6.1 4.7 6.8 6.9 7.4 10.6 14.9 13.6 12.0 18.1

EPS

40.9 37.0 40.5 76.4 32.6 19.4 22.6 11.3 8.6 6.2 3.4 4.2 7.9 -2.5

EV (Enterprise Value)

83.6 млрд 105 млрд 87.1 млрд 70.5 млрд 55.9 млрд 38.8 млрд 46.8 млрд 42.2 млрд 38.1 млрд 44.4 млрд 42.6 млрд 29.2 млрд 17.2 млрд 8.41 млрд

EBITDA per Share

41.5 41.9 47.4 87.3 35.4 22.2 24.9 20.9 13.7 12.9 8.86 8.18 5.22 -1.92

EV/EBITDA

7.6 13.9 14.5 16.3 17.8 24.8 32.0 46.5 35.5 33.6 -45.1

PEG

0.6 0.92 0.57 0.15 0.58 -1.2 0.18 1.06 1.04 0.87 -5.99 -1.49 0.05 0.38

P/B

2.6 3.9 3.7 3.6 4.7 3.3 5.2 6.6 8.1 11.8 16.5 14.7 13.3 16.6

P/CF

17.6 21.8 16.7 9.4 19.9 18.4 25.0 39.0 37.5 66.3 102.2 67.1 -133.5 -40.5

ROE %

15.03 15.22 19.14 43.03 31.86 19.08 27.91 19.51 20.13 17.40 13.69 21.74 60.24 -45.65

ROA %

11.69 11.95 14.85 31.75 20.47 14.29 20.83 13.67 12.84 11.34 8.99 14.38 36.06 -16.75

ROCE %

13.60 15.58 20.91 47.67 32.44 17.39 24.63 27.26 23.22 26.09 26.06 28.66 23.88 -17.46

Current Ratio

4.5 4.7 4.5 3.8 2.8 3.7 4.5 3.8 2.6 3.6 3.3 6.0 7.4 4.4

DSO

152.7 153.0 170.4 103.9 111.9 124.0 122.0 122.7 121.0 130.6 131.7 154.7 183.5 84.4

DIO

- - - - - 660.5 968.0 667.5 486.4 221.7 229.4 165.3 123.8 1173.6

DPO

- - - - - 195.1 183.5 163.8 164.4 131.0 177.2 145.5 168.3 2401.2

Операционный цикл

152.7 153.0 170.4 103.9 111.9 784.6 1090.0 790.2 607.4 352.3 361.1 319.9 307.3 1258.0

Финансовый цикл

152.7 153.0 170.4 103.9 111.9 589.5 906.5 626.4 443.0 221.3 184.0 174.4 139.0 -1143.3

Все данные представлены в валюте USD

Мультипликаторы поквартально Regeneron Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

12.4 13.25 6.7 9.48 9.05 7.64 - 12.31 7.9 9.12 - 15.37 29.51 10.58 10.9 7.98 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.5 5.12 4.44 1.62 3.64 3.66 2.36 2.41 2.53 1.88 1.74 1.49 2.04 1.89 0.74 0.89 0.89 0.89 0.89 0.98 1.44 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -0.49

EBITDA per Share

- - 8.03 - - 9.77 - 13.7 10.3 12.5 - 19.4 31.9 11.2 - 11.6 7.04 6.89 - 8.18 3.83 4.88 - 6.78 6.42 5.61 - 6.29 5.88 4.44 - 4.18 3.25 3.38 - 4.3 3.66 2.93 - 8.56 2.39 2.3 - 2.72 1.81 1.68 - 2.42 1.11 0.33 - -0.39 -0.5 -0.38

ROE %

16.37 15.83 14.23 17.70 19.79 19.87 15.14 24.60 27.92 44.29 39.25 49.68 47.86 35.51 31.86 28.58 26.98 20.59 19.08 21.31 22.06 26.61 27.91 21.37 20.90 20.91 19.50 22.37 22.00 20.10 20.13 18.68 18.48 19.40 17.40 16.70 14.47 12.68 14.11 15.51 19.21 20.16 21.71 54.21 62.35 64.04 59.91 11.47 -16.74 -35.77 -45.65 -12.84 -12.87 -8.94

ROA %

12.78 12.36 11.11 13.77 15.39 15.92 12.14 19.04 17.49 31.91 27.59 34.29 32.30 23.11 20.47 19.12 18.74 14.82 14.29 15.93 16.48 19.87 20.83 15.82 15.18 14.91 13.67 15.32 14.69 13.08 12.84 11.98 11.93 12.59 11.34 10.92 9.52 8.40 9.36 10.29 12.73 13.34 14.38 33.71 38.12 38.85 36.06 9.41 -4.50 -12.91 -16.75 -4.71 -4.72 -3.28

ROCE %

15.06 15.27 15.51 18.43 19.68 20.81 17.39 28.10 33.09 49.85 42.12 51.67 50.52 34.35 21.86 28.51 25.62 22.51 13.83 20.99 21.49 25.75 20.74 29.85 31.81 33.66 25.08 33.23 32.27 29.87 22.11 32.85 35.43 38.31 27.93 36.39 57.96 56.99 57.65 61.32 41.14 40.78 28.07 44.32 48.44 47.36 25.06 13.02 -15.26 -34.71 -32.89 -12.03 -12.42 -8.44

Current Ratio

4.6 4.6 4.7 4.4 4.6 4.6 4.5 4.4 - 4.1 3.8 3.7 3.4 3.1 2.8 2.8 2.8 2.8 4.0 4.0 4.0 4.0 3.9 3.9 3.9 3.9 3.3 3.3 3.3 3.3 2.8 2.8 2.8 2.8 2.9 2.9 2.9 2.9 3.0 3.0 3.0 2.9 3.0 3.0 3.0 3.0 2.5 2.5 2.5 2.5 1.6 1.6 1.6 1.6

DSO

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Финансовый цикл

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Все данные представлены в валюте USD